Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CCR2 Chemokine Receptors Enhance Growth and Cell-Cycle Progression of Breast Cancer Cells through SRC and PKC Activation
Min Yao, Wei Bin Fang, Curtis Smart, et al.
Molecular Cancer Research (2018) Vol. 17, Iss. 2, pp. 604-617
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy
Valeria Mollica Poeta, Matteo Massara, Arianna Capucetti, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 497
CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of the Ligands of Receptors CCR1, CCR2, CCR3, and CCR4
Jan Korbecki, Klaudyna Kojder, Donata Simińska, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8412-8412
Open Access | Times Cited: 323
Chemokines and their Receptors: Multifaceted Roles in Cancer Progression and Potential Value as Cancer Prognostic Markers
Hà Thị Thu, Chang Hoon Lee, Jungsook Cho
Cancers (2020) Vol. 12, Iss. 2, pp. 287-287
Open Access | Times Cited: 187
Targeting the CCL2/CCR2 Axis in Cancer Immunotherapy: One Stone, Three Birds?
Liyang Fei, Xiaochen Ren, Haijia Yu, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 147
CCL2: An Important Mediator Between Tumor Cells and Host Cells in Tumor Microenvironment
Jiakang Jin, Jinti Lin, Ankai Xu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 118
The chemokine monocyte chemoattractant protein-1/CCL2 is a promoter of breast cancer metastasis
Teizo Yoshimura, Chunning Li, Yuze Wang, et al.
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 7, pp. 714-738
Open Access | Times Cited: 50
Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy
Dina Morein, Nofar Erlichman, Adit Ben‐Baruch
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 114
Chemokines and chemokine receptors: A new strategy for breast cancer therapy
Hui Liu, Zhenjiang Yang, Wenping Lü, et al.
Cancer Medicine (2020) Vol. 9, Iss. 11, pp. 3786-3799
Open Access | Times Cited: 92
Research trends in pharmacological modulation of tumor‐associated macrophages
Neng Wang, Shengqi Wang, Xuan Wang, et al.
Clinical and Translational Medicine (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 87
Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) Drives Activation of Bone Remodelling and Skeletal Metastasis
Bridie S Mulholland, Mark R. Forwood, Nigel A. Morrison
Current Osteoporosis Reports (2019) Vol. 17, Iss. 6, pp. 538-547
Open Access | Times Cited: 84
Roles of microRNAs in Ovarian Cancer Tumorigenesis: Two Decades Later, What Have We Learned?
Ali A. Alshamrani
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 75
Chemokine networks modulating natural killer cell trafficking to solid tumors
Xue Yao, Sandro Matosevic
Cytokine & Growth Factor Reviews (2021) Vol. 59, pp. 36-45
Closed Access | Times Cited: 58
The role of CCL2/CCR2 axis in cancer and inflammation: The next frontier in nanomedicine
Sabina Pozzi, Ronit Satchi‐Fainaro
Advanced Drug Delivery Reviews (2024) Vol. 209, pp. 115318-115318
Closed Access | Times Cited: 14
Chemokines orchestrate tumor cells and the microenvironment to achieve metastatic heterogeneity
Sugandha Saxena, Rakesh K. Singh
Cancer and Metastasis Reviews (2021) Vol. 40, Iss. 2, pp. 447-476
Open Access | Times Cited: 43
Characterization of gastric cancer-stimulated signaling pathways and function of CTGF in cancer-associated fibroblasts
Kyoung‐Min Choi, Boram Kim, Su‐Min Lee, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
PKCδ mediates mitochondrial ROS generation and oxidation of HSP60 to relieve RKIP inhibition on MAPK pathway for HCC progression
Jayaprakash Mandal, Chiou-Nan Shiue, Yen-Cheng Chen, et al.
Free Radical Biology and Medicine (2020) Vol. 163, pp. 69-87
Open Access | Times Cited: 41
Anesthetic Propofol Promotes Tumor Metastasis in Lungs via GABAAR‐Dependent TRIM21 Modulation of Src Expression
Qidong Liu, Zhihao Sheng, Chun Cheng, et al.
Advanced Science (2021) Vol. 8, Iss. 18
Open Access | Times Cited: 33
Unveiling the role of PANoptosis-related genes in breast cancer: an integrated study by multi-omics analysis and machine learning algorithms
Gang Liu, Liang-Zhi Pan, Jie Chen, et al.
Breast Cancer Research and Treatment (2025)
Closed Access
CCR2 signaling in breast carcinoma cells promotes tumor growth and invasion by promoting CCL2 and suppressing CD154 effects on the angiogenic and immune microenvironments
Gage Brummer, Wei Bin Fang, Curtis Smart, et al.
Oncogene (2019) Vol. 39, Iss. 11, pp. 2275-2289
Open Access | Times Cited: 39
MCP-1/CCR2 axis inhibition sensitizes the brain microenvironment against melanoma brain metastasis progression
Sabina Pozzi, Anna Scomparin, Dikla Ben‐Shushan, et al.
JCI Insight (2022) Vol. 7, Iss. 17
Open Access | Times Cited: 19
Mesothelial Cell HIF1α Expression Is Metabolically Downregulated by Metformin to Prevent Oncogenic Tumor-Stromal Crosstalk
Peter C. Hart, Hilary A. Kenny, Niklas Graßl, et al.
Cell Reports (2019) Vol. 29, Iss. 12, pp. 4086-4098.e6
Open Access | Times Cited: 34
Ultrasound molecular imaging-guided tumor gene therapy through dual-targeted cationic microbubbles
Yingying Liu, Yuli Zhou, Jinfeng Xu, et al.
Biomaterials Science (2021) Vol. 9, Iss. 7, pp. 2454-2466
Closed Access | Times Cited: 26
Stromal cells in the tumor microenvironment promote the progression of oral squamous cell carcinoma
Qiusheng Shan, Kiyofumi Takabatake, Haruka Omori, et al.
International Journal of Oncology (2021) Vol. 59, Iss. 3
Open Access | Times Cited: 24
Therapeutic targeting with DABIL‐4 depletes myeloid suppressor cells in 4T1 triple‐negative breast cancer model
Sadiya Parveen, Sumit Siddharth, Laurene S. Cheung, et al.
Molecular Oncology (2021) Vol. 15, Iss. 5, pp. 1330-1344
Open Access | Times Cited: 22
Chemokine CCL2 promotes cardiac regeneration and repair in myocardial infarction mice via activation of the JNK/STAT3 axis
Wei Wang, Xiaokang Chen, Lu Zhou, et al.
Acta Pharmacologica Sinica (2023) Vol. 45, Iss. 4, pp. 728-737
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top